ZOEY OROPALLO: Open Payments
NPI 1730771155 · SMYRNA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,161 in 62 payments from 19 companies in 2025. Trend: 2023 $534 · 2024 $993 · 2025 $1,161
Food & beverage: $1,161
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $278 |
| Astellas Pharma US Inc | 8 | $154 |
| AstraZeneca Pharmaceuticals LP | 7 | $123 |
| Lilly USA, LLC | 5 | $88 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Dynavax Technologies Corporation | 2 | $50 |
| SHIELD THERAPEUTICS INC | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| SANOFI-AVENTIS U.S. LLC | 2 | $40 |
Products named: Veozah, Wegovy, Ozempic, JARDIANCE, AIRSUPRA, SHINGRIX, BREZTRI, MOUNJARO.
Industry payments across GA — which companies pay providers there.
